【摘要】：公共衛(wèi)生需要?jiǎng)?chuàng)新，也需要每個(gè)需要醫(yī)治的病人都能獲取高質(zhì)量的醫(yī)療產(chǎn)品，藥品可及性的程度直接關(guān)系到人類的健康，保障藥品可及性是政府義不容辭的責(zé)任。目前，我國藥品可及性問題是影響我國和諧社會(huì)構(gòu)建的突出問題。 本篇論文由五個(gè)部分構(gòu)成，第一部分著重闡述了本次研究的背景和本次研究的意義，同時(shí)綜述了國內(nèi)外權(quán)威學(xué)者在該領(lǐng)域的研究現(xiàn)狀及成果。第二部分為藥品可及性保障概述，主要介紹藥品可及性的含義，并以此為研究對象，介紹了與藥品可及性保障相關(guān)的三大法律制度—藥品管理法律制度、醫(yī)療保障法律制度和藥品專利制度；另對藥品可及性保障的法律制度的理論基礎(chǔ)進(jìn)行了介紹。第三部分對國外典型國家藥品可及性保障的法律問題進(jìn)行介紹，分別對美國、日本、印度三個(gè)國家的藥品可及性法律問題作為對比，提出各自的優(yōu)勢和不足，并提出發(fā)達(dá)國家和發(fā)展中國家藥品可及性保障的法律制度對我國的借鑒與啟示。第四部分為中國的藥品可及性保障的法律的現(xiàn)狀及問題，從藥品管管理、醫(yī)療保障及藥品專利三個(gè)方面分別對我國藥品可及性保障法律的現(xiàn)狀和存在的問題作詳細(xì)論述。第五部分為完善我國藥品可及性法律制度的對策，在前述的基礎(chǔ)上針對三大制度提出相應(yīng)對策。 隨著我國醫(yī)藥市場的發(fā)展，我國的公共健康面臨著不太樂觀的形勢，我國有關(guān)的藥品部門必須要采取強(qiáng)力措施來應(yīng)對，從而較為深層次的提高我國的醫(yī)藥創(chuàng)新能力，盡可能的使藥品價(jià)格降低到適合我國經(jīng)濟(jì)發(fā)展的水平，，從比較根本層次解決買藥困難這一重大民生問題；相關(guān)立法部門加強(qiáng)立法，維護(hù)醫(yī)藥企業(yè)的正當(dāng)權(quán)益，采取一定的嚴(yán)厲措施，進(jìn)一步促進(jìn)本國醫(yī)藥產(chǎn)業(yè)朝著協(xié)調(diào)的方向發(fā)展。
[Abstract]:Public health needs innovation, and every patient in need of medical treatment can obtain high quality medical products. The degree of drug accessibility is directly related to human health, and it is the government's duty to ensure drug accessibility. At present, the problem of drug accessibility is a prominent problem affecting the construction of a harmonious society in China. This paper is composed of five parts. The first part focuses on the background and significance of this study, and summarizes the research status and achievements of domestic and foreign authoritative scholars in this field. The second part is an overview of drug accessibility, mainly introduces the meaning of drug accessibility, and as a research object, introduces three major legal systems related to drug accessibility-drug management legal system. The legal system of medical security and the patent system of drugs; In addition, the theoretical basis of the legal system of drug accessibility is introduced. The third part introduces the legal problems of drug accessibility in typical foreign countries, and compares the legal problems of drug accessibility between the United States, Japan and India, and puts forward their respective advantages and disadvantages. It also puts forward the reference and enlightenment of the legal system of drug accessibility protection in developed and developing countries. The fourth part is the current situation and problems of the law of drug accessibility protection in China. From the aspects of drug management, medical security and drug patent, the current situation and existing problems of the law of drug accessibility in China are discussed in detail. The fifth part is to improve the legal system of drug accessibility in China, on the basis of the above put forward the corresponding countermeasures for the three systems. With the development of medicine market in our country, the public health of our country is facing a situation which is not very optimistic. The relevant pharmaceutical departments in our country must take strong measures to deal with it, so as to improve the ability of innovation of medicine in our country at a deeper level. As far as possible to reduce the price of drugs to the level of economic development in China, from a more fundamental level to solve the difficulty of buying drugs this major livelihood problem; The relevant legislative departments should strengthen legislation, safeguard the legitimate rights and interests of pharmaceutical enterprises, take strict measures to further promote the development of domestic pharmaceutical industry in the direction of coordination.
【學(xué)位授予單位】：武漢工程大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：D922.16;D923.42

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 徐興祥;;論影響藥物可及性的因素[J];法治研究;2009年06期

2 徐興祥;;藥物可及性與知識(shí)產(chǎn)權(quán)保護(hù)——從甲型H1N1流感防治談起[J];電子知識(shí)產(chǎn)權(quán);2009年06期

3 楊清紅;;農(nóng)村醫(yī)療衛(wèi)生服務(wù)的可及性研究——基于CHNS數(shù)據(jù)的實(shí)證分析[J];暨南學(xué)報(bào)(哲學(xué)社會(huì)科學(xué)版);2012年08期

4 ;[J];;年期

5 ;[J];;年期

6 ;[J];;年期

7 ;[J];;年期

8 ;[J];;年期

9 ;[J];;年期

10 ;[J];;年期

相關(guān)會(huì)議論文 前10條

1 龔時(shí)薇;許q

本文編號(hào)：2408964